Antimicrobials from a feline commensal bacterium inhibit skin infection by drug-resistant S. pseudintermedius

  1. Alan M O'Neill
  2. Kate A Worthing
  3. Nikhil Kulkarni
  4. Fengwu Li
  5. Teruaki Nakatsuji
  6. Dominic McGrosso
  7. Robert H Mills
  8. Gayathri Kalla
  9. Joyce Y Cheng
  10. Jacqueline M Norris
  11. Kit Pogliano
  12. Joe Pogliano
  13. David J Gonzalez
  14. Richard L Gallo  Is a corresponding author
  1. University of California San Diego, United States
  2. University of Arizona, United States
  3. University of Sydney, Australia
  4. University of California, San Diego, United States

Abstract

Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is an important emerging zoonotic pathogen that causes severe skin infections. To combat infections from drug-resistant bacteria, the transplantation of commensal antimicrobial bacteria as a therapeutic has shown clinical promise. We screened a collection of diverse staphylococcus species from domestic dogs and cats for antimicrobial activity against MRSP. A unique strain (S. felis C4) was isolated from feline skin that inhibited MRSP and multiple gram-positive pathogens. Whole genome sequencing and mass spectrometry revealed several secreted antimicrobials including a thiopeptide bacteriocin micrococcin P1 and phenol-soluble modulin beta (PSMβ) peptides that exhibited antimicrobial and anti-inflammatory activity. Fluorescence and electron microscopy revealed that S. felis antimicrobials inhibited translation and disrupted bacterial but not eukaryotic cell membranes. Competition experiments in mice showed that S. felis significantly reduced MRSP skin colonization and an antimicrobial extract from S. felis significantly reduced necrotic skin injury from MRSP infection. These findings indicate a feline commensal bacterium that could be utilized in bacteriotherapy against difficult-to-treat animal and human skin infections.

Data availability

The RNA Sequencing data has been deposited in Dryad with a unique DOI identifier provided:doi:10.6076/D10019

The following data sets were generated

Article and author information

Author details

  1. Alan M O'Neill

    Dermatology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5892-6477
  2. Kate A Worthing

    Veterinary Medicine, University of Arizona, Arizona, United States
    Competing interests
    Kate A Worthing, Dr. Worthing is a co-inventor of technology described in this manuscript that has been disclosed to the University of California San Diego..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8713-7189
  3. Nikhil Kulkarni

    Dermatology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  4. Fengwu Li

    Dermatology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  5. Teruaki Nakatsuji

    Dermatology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  6. Dominic McGrosso

    Dermatology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  7. Robert H Mills

    Pharmacology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  8. Gayathri Kalla

    Pharmacology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  9. Joyce Y Cheng

    Dermatology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  10. Jacqueline M Norris

    Veterinary Science, University of Sydney, Sydney, Australia
    Competing interests
    No competing interests declared.
  11. Kit Pogliano

    Division of Biological Sciences, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7868-3345
  12. Joe Pogliano

    Division of Biological Sciences, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  13. David J Gonzalez

    Department of Pharmacology, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  14. Richard L Gallo

    Dermatology, University of California San Diego, San Diego, United States
    For correspondence
    rgallo@health.ucsd.edu
    Competing interests
    Richard L Gallo, is a co-founder, scientific advisor, consultant and has equity in MatriSys Biosciences and is a consultant, receives income and has equity in Sente.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1401-7861

Funding

National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK007202)

  • Robert H Mills

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments involving live animal work were performed in accordance with the approval of the University of California, San Diego Institutional Animal Care and Use Guidelines (protocol no. S09074)

Copyright

© 2021, O'Neill et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,637
    views
  • 530
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Alan M O'Neill
  2. Kate A Worthing
  3. Nikhil Kulkarni
  4. Fengwu Li
  5. Teruaki Nakatsuji
  6. Dominic McGrosso
  7. Robert H Mills
  8. Gayathri Kalla
  9. Joyce Y Cheng
  10. Jacqueline M Norris
  11. Kit Pogliano
  12. Joe Pogliano
  13. David J Gonzalez
  14. Richard L Gallo
(2021)
Antimicrobials from a feline commensal bacterium inhibit skin infection by drug-resistant S. pseudintermedius
eLife 10:e66793.
https://doi.org/10.7554/eLife.66793

Share this article

https://doi.org/10.7554/eLife.66793

Further reading

    1. Microbiology and Infectious Disease
    Lesia Semenova, Yingfan Wang ... Edward P Browne
    Research Article

    Understanding the interplay between the HIV reservoir and the host immune system may yield insights into HIV persistence during antiretroviral therapy (ART) and inform strategies for a cure. Here, we applied machine learning (ML) approaches to cross-sectional high-parameter HIV reservoir and immunology data in order to characterize host–reservoir associations and generate new hypotheses about HIV reservoir biology. High-dimensional immunophenotyping, quantification of HIV-specific T cell responses, and measurement of genetically intact and total HIV proviral DNA frequencies were performed on peripheral blood samples from 115 people with HIV (PWH) on long-term ART. Analysis demonstrated that both intact and total proviral DNA frequencies were positively correlated with T cell activation and exhaustion. Years of ART and select bifunctional HIV-specific CD4 T cell responses were negatively correlated with the percentage of intact proviruses. A leave-one-covariate-out inference approach identified specific HIV reservoir and clinical–demographic parameters, such as age and biological sex, that were particularly important in predicting immunophenotypes. Overall, immune parameters were more strongly associated with total HIV proviral frequencies than intact proviral frequencies. Uniquely, however, expression of the IL-7 receptor alpha chain (CD127) on CD4 T cells was more strongly correlated with the intact reservoir. Unsupervised dimension reduction analysis identified two main clusters of PWH with distinct immune and reservoir characteristics. Using reservoir correlates identified in these initial analyses, decision tree methods were employed to visualize relationships among multiple immune and clinical–demographic parameters and the HIV reservoir. Finally, using random splits of our data as training-test sets, ML algorithms predicted with approximately 70% accuracy whether a given participant had qualitatively high or low levels of total or intact HIV DNA . The techniques described here may be useful for assessing global patterns within the increasingly high-dimensional data used in HIV reservoir and other studies of complex biology.

    1. Microbiology and Infectious Disease
    Srinivasan Vijay, Nguyen Le Hoai Bao ... Nguyen Thuy Thuong
    Research Article

    Antibiotic tolerance in Mycobacterium tuberculosis reduces bacterial killing, worsens treatment outcomes, and contributes to resistance. We studied rifampicin tolerance in isolates with or without isoniazid resistance (IR). Using a minimum duration of killing assay, we measured rifampicin survival in isoniazid-susceptible (IS, n=119) and resistant (IR, n=84) isolates, correlating tolerance with bacterial growth, rifampicin minimum inhibitory concentrations (MICs), and isoniazid-resistant mutations. Longitudinal IR isolates were analyzed for changes in rifampicin tolerance and genetic variant emergence. The median time for rifampicin to reduce the bacterial population by 90% (MDK90) increased from 1.23 days (IS) and 1.31 days (IR) to 2.55 days (IS) and 1.98 days (IR) over 15–60 days of incubation, indicating fast and slow-growing tolerant sub-populations. A 6 log10-fold survival fraction classified tolerance as low, medium, or high, showing that IR is linked to increased tolerance and faster growth (OR = 2.68 for low vs. medium, OR = 4.42 for low vs. high, p-trend = 0.0003). High tolerance in IR isolates was associated with rifampicin treatment in patients and genetic microvariants. These findings suggest that IR tuberculosis should be assessed for high rifampicin tolerance to optimize treatment and prevent the development of multi-drug-resistant tuberculosis.